Friday September 19, 2014


08.00
Welcome coffee
08.15

Introduction

Speaker : P. Métellus - FR |
08.30

Basic Science & Translational Research Perspectives

  • 08.30 - Brain metastases preclinical models, P. Steeg, USA
  • 09.00 - Genomic Characterization of Brain Metastases Reveals Branched, Evolution and Metastasis-Specific Mutations, P. Brastianos, USA
  • 09.30 - Brain metastases and methylation profile, C. Geisenberger, DE
  • 10.00 - Circulating tumor cells and brain metastases outcome in HER2-positive breast cancer patients, J-Y. Pierga, FR
Attached file :
Moderators : D. Figarella-Branger - FR | P. Steeg - USA |
10.30
Coffee break and visit of the exhibition
11.00

Integrated Targeted Therapies Strategies (Part 1)

  • 11.00 - Graded prognostic Indices at the age of molecular profiling and targeted therapies, M. Ahluwalia, USA
  • 11.30 - Targeted therapies in BRAF-mutant brain metastatic melanoma patients, C. Mateus, FR
Moderators : P. Métellus - FR | A. Tallet - FR |
12.00

Integrated Targeted Therapies Strategies (Part 2)

  • 12.00 - Systemic therapy for breast cancer in the brain: future potential, D. Cameron, UK
  • 12.30 - Targeted therapies and brain metastases in lung cancer patients, B. Besse, FR
Attached files :
Moderators : E.C. Moser - POR | Frank Winkler - DE |
13.00
Lunch
13.30

Symposium BMS

  • 13.30 - Immuno-Oncology in Brain Metastases Concept of Immuno-Oncology and Immunotherapy on Brain Metastases in lung cancer, F. Barlési - FR
  • 14.00 - Immunotherapy on Brain Metastases un melanoma, S. Monestier-Gasmi - FR
Attached files :
Moderator : JJ. Grob - FR |
14.30

Innovative Trial Concepts

  • 14.30 - Innovative trial concepts in Brain Metastases, M. Mehta - USA
  • 15.00 - Window of Opportunity studies in Brain Metastases, J-C. Tönn - DE
Attached files :
Moderators : M. Preusser - AUT | Z. Ram - IL |
15.30

Neuroimaging endpoints in clinical trials

  • 15.30 - Neuroimaging assessment of brain metastases in the targeted therapy era, A. Radbruch, DE
Attached file :
Moderators : F. Dhermain - FR | M. Mehta - USA |
16.00

Neurocognition and QoL Assessment

  • 16.00 - Chemotherapy related cognitive deficits, S. Schagen, NL
  • 16.30 - Neurocognitive assessment in BM, M. Klein, NL
Attached files :
Moderators : M. Klein - NL | Emilie Le Rhun - Lille, France |
17.00

Symposium Brainlab

Automatic Brain Metastases Planning: Fast Treatment. Focused Dose. Revolutionary Technology.
The biological response of brain metastases to stereotactic radiotherapy, R. Zakaria - UK

17.45

Poster session (with guided poster walks, cheese & wine)

20.00
Gala Dinner
Top